A Study of the Efficacy and Safety of MK-5475 in Participants with Pulmonary Arterial Hypertension

2023-02-08T13:13:14-05:00January 30th, 2023|

Population: Pulmonary Arterial Hypertension in adults ages 18-75 years old (inclusive) Start Date: May 19, 2021 End Date: February 9, 2026 Phase: Phase 2/Phase 3 Institution: Multi-center Study Website: https://www.INSIGNIA-PAHstudy.com The INSIGNIA-PAH Clinical Trial will test an investigational drug in adults ages 18 to 75 who have pulmonary